Rendering

Component: (Network and Table)
Network
00000036 - Disclosure - Share-based Payments (Tables)
(http://akersbiosciences.com/role/SharebasedPaymentsTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001321834 (http://www.sec.gov/CIK)
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]Period [Axis]
2015-01-01 - 2015-12-31
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
 
Schedule of Share-based Compensation Warrants Activity

The following table summarizes the warrant activities for the years ended December 31, 2015 and 2014:

 

          Weighted  
    Number of     Average  
    Shares     Exercise Price  
Balance at December 31, 2014 and 2013     1,989     $ 71.76  
 Granted     -       -  
 Exercised     -       -  
 Forfeited     -       -  
 Canceled/Expired     (1,989 )     71.76  
Balance at December 31, 2015     -     $ -  

 

  
Schedule of operations and comprehensive loss

The calculated fair value of these options was distributed to the following categories on the consolidated statement of operations and comprehensive loss:

 

Expense Category   2015     2014  
Cost of Goods   $ 5,909     $ 24,040  
General & Administrative     -       357,276  
Sales & Marketing     1,617       48,081  
Research & Development     44,830       120,203  
    $ 52,356     $ 549,600  

  
Schedule of Options And Warrants Valuation Assumptions Under Black Scholes Pricing Model

The options and warrants issued under the above plan were valued using a Black Scholes option pricing model. The assumptions utilized in calculating the value of the issued options under Black Scholes are as follows:

 

    2015     2014  
Expected option term      5 yrs        5 yrs  
Expected volatility     82.86 %     127.32 %
Expected dividend yield     0.00 %     0.00 %
Risk free interest rate     1.73 %     1.71 %

  
Summary of Stock Options Activity

The following table summarizes the option activities for the years ended December 31, 2015 and 2014:

 

                Weighted        
          Weighted     Average        
          Average     Remaining     Aggregate  
    Number of     Exercise     Contractual     Intrinsic  
    Shares     Price     Term (years)     Value  
Balance at December 31, 2013     -     $ -                  
 Granted     175,000       4.98                  
 Exercised     -       -                  
 Forfeited     -       -                  
 Canceled/Expired     -       -                  
Balance at December 31, 2014     175,000     $ 4.98                  
Exercisable as of December 31, 2014     175,000     $ 4.98       4.50     $ 600  
                                 
Balance at December 31, 2014     175,000     $ 4.98                  
 Granted     45,500       2.07                  
 Exercised     -       -                  
 Forfeited     -       -                  
 Canceled/Expired     -       -                  
Balance at December 31, 2015     220,500     $ 4.38                  
Exercisable as of December 31, 2015     220,500     $ 4.38       3.81     $ -